Anti-TNF agents led to mucosal healing in a subgroup of IBD patients; however, many patients do not respond to anti-TNF treatment.4 New therapeutic targets and pharmacologic approaches are still highly desired for IBDs. The gene discussed is TNF; the disease is inflammatory bowel disease.